Gaps in Hypertension Guidelines in Low- and Middle-Income Versus High-Income Countries: A Systematic Review

Hypertension

Volumn 68, Issue 6, 2016, Pages 1328-1337

  Owolabi, Mayowa ^a,c   Olowoyo, Paul ^d   Miranda, J Jaime ^e   Akinyemi, Rufus ^b   Feng, Wuwei ^f   Yaria, Joseph ^a   Makanjuola, Tomiwa ^a   Yaya, Sanni ^g   Kaczorowski, Janusz ^h   Thabane, Lehana ⁱ   Van Olmen, Josefien ^j   Mathur, Prashant ^k   Chow, Clara ^l   Kengne, Andre ^m   Saulson, Raelle ^f   Thrift, Amanda G ⁿ   Joshi, Rohina ^l   Bloomfield, Gerald S ^o   Gebregziabher, Mulugeta ^f   Parker, Gary ^p   Agyemang, Charles ^q   Modesti, Pietro Amedeo ^r   Norris, Shane ^s   Ogunjimi, Luqman ^a   Farombi, Temitope ^a   Melikam, Ezinne Sylvia ^a   Uvere, Ezinne ^c   Salako, Babatunde ^a   Ovbiagele, Bruce ^f   more..

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c WFNR Blossom Center for Neurorehabilitation   (Nigeria)

^d Federal Teaching Hospital   (Nigeria)

^e CRONICAS CENTER OF EXCELLENCE IN CHRONIC DISEASES   (Peru)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g UNIVERSITY OF OTTAWA   (Canada)

^h UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ Hamilton Health Service Organization Mental Health and Nutrition Program   (Canada)

^j MCMASTER UNIVERSITY   (Canada)

^k GOVERNMENT OF INDIA   (India)

^l UNIVERSITY OF SYDNEY   (Australia)

^m SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

ⁿ MONASH UNIVERSITY   (Australia)

^o DUKE UNIVERSITY MEDICAL CENTER   (United States)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

^q UNIVERSITY OF AMSTERDAM   (Netherlands)

^r UNIVERSITY OF FLORENCE   (Italy)

^s UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

DISEASE CONTROL; HIGH INCOME COUNTRY; HUMAN; HYPERTENSION; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; REVIEW; SOCIOECONOMICS; SYSTEMATIC REVIEW; ADULT; AGED; COMPARATIVE STUDY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ECONOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; INCOME; INTERNATIONAL COOPERATION; MIDDLE AGED;

ADULT; AGED; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HEALTH CARE COSTS; HEALTH PERSONNEL; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYPERTENSION; INCOME; INTERNATIONALITY; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC;

EID: 84994885340     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.08290     Document Type: Review

References (61)

1. Cao X. A call for global research on non-communicable diseases. Lancet. 2015;385:e5-e6. doi: 10.1016/S0140-6736(14)62383-7.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223. doi: 10.1016/S0140-6736(05)17741-1.
3. Naghavi M, Wang H, Lozano R, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117-171. doi: 10.1016/S0140-6736(14)61682-2.
4. Hameed K, Kadir M, Gibson T, Sultana S, Fatima Z, Syed A. The frequency of known diabetes, hypertension and ischaemic heart disease in affluent and poor urban populations of Karachi, Pakistan. Diabet Med. 1995;12:500-503.
5. van de Vijver S, Akinyi H, Oti S, et al. Status report on hypertension in Africa-consultative review for the 6th Session of the African Union Conference of Ministers of Health on NCD's. Pan African Medical Journal. 2014;16.
6. Seedat YK. Hypertension in developing nations in sub-Saharan Africa. J Hum Hypertens. 2000;14:739-747.
7. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation. 2005;112:3562-3568. doi: 10.1161/CIRCULATIONAHA.105.539569.
8. Liu LS; Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:579-615.
9. Nwankwo T, Yoon S, Burt V, Gu Q. Hypertension among adults in the US: National Health and Nutrition Examination Survey, 2011-2012. NCHS data brief, no. 133. National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD, US Dept of Health and Human Services Ref Type: Report. 2013.
10. Odili V, Oghagbon E, Ugwa N, Ochei U, Aghomo O. Adherence to international guidelines in the management of hypertension in a tertiary hospital in Nigeria. Trop J Pharm Res. 2008;7:945-952.
11. Williams B. Recent hypertension trials: implications and controversies. J Am Coll Cardiol. 2005;45:813-827. doi: 10.1016/j.jacc.2004.10.069.
12. Saunders E. Hypertension in African-Americans. Circulation. 1991;83:1465-1467.
13. Baker EH, Ireson NJ, Carney C, Markandu ND, MacGregor GA. Transepithelial sodium absorption is increased in people of African origin. Hypertension. 2001;38:76-80.
14. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9, W64.
15. Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines; Board on Health Care Services Clinical Practice Guidelines We can Trust. Washington, DC, National Academies Press; 2011.
16. Kung J, Miller RR, Mackowiak PA. Failure of clinical practice guidelines to meet institute of medicine standards: Two more decades of little, if any, progress. Arch Intern Med. 2012;172:1628-1633. doi: 10.1001/2013. jamainternmed.56.
17. Owolabi MO, Akarolo-Anthony S, Akinyemi R, et al; Members of the H3Africa Consortium. The burden of stroke in Africa: a glance at the present and a glimpse into the future. Cardiovasc J Afr. 2015;26(2 suppl 1):S27-S38. doi: 10.5830/CVJA-2015-038.
18. Z Score Calculator for 2 Population Proportions. http://www.socscistatistics. com/tests/ztest/Default2.aspx Z Score Calculator for 2 Poulation Proportions. Accessed June 24, 2016.
19. Rau NR, Nayak SK. Practical guidelines for hypertension management. http://www.apiindia.org/medicine-update-2013/chap17.pdf. Accessed May 15, 2016.
20. Wijesisiwardene B, Mohideen R. Clinical practice guidelines. http://www. slcog.lk/img/guidelines/Other%20national%20Gidelines/Physicians/Book%201/Management%20of%20Hypertension.pdf. Accessed May 15, 2016.
21. Tadesse Y. Ethiopia standard treatment guidelines. http://siapsprogram. org/publication/ethiopia-standard-treatment-guidelines/". Accessed June 2, 2016.
22. Sulima AA, Aboud MH. Sudan hypertension guidelines. http://ssh-sd. org/fileload/sudan%20hypertension%20guidelines.pdf. Accessed June 2, 2016.
23. Guide to Management of Hypertension 2008. www.heartfoundation.org. au/Professional-Information/Clinical-Practice/Hypertension. Accessed June 6, 2016.
24. Crouch M. 2009 Kenya guideline for hypertension management. http://apps.who.int/medicinedocs/documents/s21000en/s21000en.pdf. Accessed July 5, 2016.
25. Onwubere B, Kadiri S. Guidelines for the management of hypertension in Nigeria. In: Nigerian Hypertension Society Enugu. Ezu Books Limited. 2005:1-4.
26. Seedat YK, Rayner BL; Southern African Hypertension Society. South African hypertension guideline 2011. S Afr Med J. 2012;102(1 pt 2):57-83.
27. Sociedade BdH, Cardiologia SBd, Nefrologia SBd. VI Brazilian guidelines on hypertension. Arq Bras Cardiol. 2010;95:1.
28. Rosas M, Pastelin G, Vargas-Alarcon G et al.. Arch Inst Cardiol Mex. 2007;78:S2-5-57.
29. Shimamoto K, Ando K, Fujita T, et al; Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253-390. doi: 10.1038/hr.2014.20.
30. Aronow WS. Hypertension guidelines. Hypertension. 2011;58:347-348. doi: 10.1161/HYPERTENSIONAHA.111.177147.
31. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Pressure. 2013;22:193-278.
32. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. doi: 10.1001/jama.2013.284427.
33. Blacher J, Halimi JM, Hanon O, Mourad JJ, Pathak A, Schnebert B, Girerd X; French Society of Hypertension. Management of hypertension in adults: the 2013 French Society of Hypertension guidelines. Fundam Clin Pharmacol. 2014;28:1-9. doi: 10.1111/fcp.12044.
34. Chiang CE, Wang TD, Li YH, Lin TH, Chien KL, Yeh HI, Shyu KG, Tsai WC, Chao TH, Hwang JJ, Chiang FT, Chen JH; Hypertension Committee of the Taiwan Society of Cardiology. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension. J Formos Med Assoc. 2010;109:740-773. doi: 10.1016/S0929-6646(10)60120-9.
35. Wood S. ASH/ISH issue separate hypertension guidelines from JNC 8, hinting at discord. Medscape. 2013;19.
36. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol. 2011;57:2037-2114. doi: 10.1016/j.jacc.2011.01.008.
37. Dasgupta K, Quinn RR, Zarnke KB, et al; Canadian Hypertension Education Program. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2014;30:485-501. doi: 10.1016/j.cjca.2014.02.002.
38. Go AS, Bauman MA, Coleman King SM, Fonarow GC, Lawrence W, Williams KA, Sanchez E; American Heart Association; American College of Cardiology; Centers for Disease Control and Prevention. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension. 2014;63:878-885. doi: 10.1161/HYP.0000000000000003.
39. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403-1419. doi: 10.1161/HYPERTENSIONAHA.108.189141.
40. Ritchie LD, Campbell NC, Murchie P. New NICE guidelines for hypertension. BMJ. 2011;343:d5644.
41. Argentina: Guias de la Sociedad Argentina de Hipertension para el Diagnostico, Estudio, Tratamiento y Seguimiento de la Hipertension Arterial. http://www.saha.org.ar/1/pdf/GUIA-SAHA-VERSION-COMPLETA.pdf. Accessed August 19, 2016.
42. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ; GRADE Working Group. What is "quality of evidence" and why is it important to clinicians? BMJ. 2008;336:995-998. doi: 10.1136/bmj.39490.551019.BE.
43. Ayanian JZ, Landon BE, Newhouse JP, Zaslavsky AM. Racial and ethnic disparities among enrollees in Medicare Advantage plans. N Engl J Med. 2014;371:2288-2297. doi: 10.1056/NEJMsa1407273.
44. Whelton PK, Beevers DG, Sonkodi S. Strategies for improvement of awareness, treatment and control of hypertension: results of a panel discussion. J Hum Hypertens. 2004;18:563-565. doi: 10.1038/sj.jhh.1001738.
45. Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton PK, He J. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension. 2004;43:578-585. doi: 10.1161/01.HYP.0000116302.08484.14.
46. World Health Organization, Group ISoHW. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hyp. 2003;21:1983-1992.
47. Whitworth JA, Chalmers J. World Health Organisation-International Society of Hypertension (WHO/ISH) hypertension guidelines. Clin Exp Hypertens. 2004;26:747-752.
48. Brasília: Ministério da Saúde. Estratégias para o cuidado da pessoa com doença crônica: hipertensão arterial sistêmica. (Cadernos de Atenção Básica, n. 37; 2013.) http://dab.saude.gov.br/portaldab/biblioteca. php?conteudo=publicacoes/cab37. Accessed August 19, 2016.
49. Chile: Ministerio de Salud. Guía Clínica 2010 Hipertensión Arterial Primaria o esencial en personas de 15 años y más. Santiago: Minsal, 2010. http://www.minsal.gob.cl/portal/url/item/7220fdc4341c44a9e04001011f 0113b9.pdf. Accessed August 19, 2016.
50. Colombia: Sistema General de Seguridad Social en Salud. Guía de práctica clínica: Hipertensión Arterial Primaria (HTA). 2013-Guía No. 18. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/IETS/GPC-Ptes-HTA.pdf. Accessed August 19, 2016.
51. Costa Rica: Caja Costarricense de Seguro Social. Guias para la Detección, Diagnóstico y Tratamiento de la Hipertensión Arterial. III Edición. San José, Costa Rica, 2009 http://www.binasss.sa.cr/libros/hipertension09. pdf. Accessed August 19, 2016.
52. México: Instituto Mexicano del Seguro Social; 08/07/2014. Diagnóstico y Tratamiento de la Hipertensión Arterial en el Primer Nivel de Atención. http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/076-GCP-HipertArterial1NA/HIPERTENSION-EVR-CENETEC.pdf. Accessed August 19, 2016.
53. Peru: Ministerio de Salud. Guía Técnica: Guía de Práctica Clínica para la Diagnóstico, Tratamiento y Control de la Enfermedad Hipertensiva; January 19, 2015. http://www.minsa.gob.pe/dgsp/documentos/Guias/RM031-2015-MINSA.pdf. Accessed August 19, 2016.
54. Panamá: Organización Panamericana de la Salud. Guía para la atención integral de las personas con Hipertensión arterial. Impresora Pacifico, 2009. http://www.paho.org/pan/index.php?option=com-docman&task=doc- view&gid=298 &Itemid=224. Accessed August 19, 2016.
55. Argentina: La Revista Argentina de Cardiología. Consenso de Hipertensión Arterial. Vol 81 Suplemento 2, Agosto 2013. http://www.sac. org.ar/wp-content/uploads/2014/04/Consenso-de-Hipertension-Arterial. pdf. Accessed August 19, 2016.
56. Morrison A, Moulton K, Clark M, Polisena J, Fiander M, Mierzwinski-Urban M, Mensinkai S, Clifford T, Hutton B. English-Language Restriction When Conducting Systematic Review-Based Meta-Analyses: Systematic Review Of Published Studies. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2009.
57. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium. The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines. J Clin Epidemiol. 2012;65:526-534. doi: 10.1016/j. jclinepi.2011.10.008.
58. Adler AJ, Prabhakaran D, Bovet P, Kazi DS, Mancia G, Mungal-Singh V, Poulter N. Reducing Cardiovascular Mortality Through Prevention and Management of Raised Blood Pressure: A World Heart Federation Roadmap. Glob Heart. 2015;10:111-122. doi: 10.1016/j.gheart.2015.04.006.
59. McAlister FA, Feldman RD, Wyard K, Brant R, Campbell NR; CHEP Outcomes Research Task Force. The impact of the Canadian Hypertension Education Programme in its first decade. Eur Heart J. 2009;30:1434-1439. doi: 10.1093/eurheartj/ehp192.
60. Field MJ, Lohr KN. Attributes of Good Practice Guidelines. Washington, DC, National Academies Press; 1990.
61. Owolabi M, Miranda JJ, Yaria J, Ovbiagele B. Controlling cardiovascular diseases in low-and middle-income countries by placing proof in pragmatism. BMJ Global Health. doi: 10.1136/bmjgh-2016-000105. In press.